Literature DB >> 8922567

Increased macrophage-colony stimulating factor levels in neonates with perinatal complications.

K Ikeno1, K Koike, T Fukuromoto, T Shimizu, M Nagatomo, A Komiyama.   

Abstract

OBJECTIVE: To examine whether perinatal complications induce the production of macrophage-colony stimulating factor (M-CSF), we have compared M-CSF levels in the cord blood between normal neonates and neonates with complications.
METHODS: The M-CSF levels were determined by enzyme-linked immunosorbent assay (ELISA).
RESULTS: In 54 normal neonates, the M-CSF level was 1859 +/- 287 U/ml (mean +/- S.D.), being significantly higher than the serum M-CSF level in normal adults (697 +/- 132 U/ml). Compared with M-CSF levels in normal neonates, significantly higher levels were evidenced in neonates with perinatal complications including premature rupture of the membranes, neonatal asphyxia, meconium staining of the amniotic fluid and maternal anemia. However, no difference in M-CSF concentrations was observed irrespective of complication types; furthermore, the M-CSF level was highly correlated with the leukocyte counts in the neonates with complications, but not in normal neonates. Incidentally, CRP levels were within normal limits in most of these neonates,
CONCLUSION: M-CSF levels in the cord blood from neonates with premature rupture of the membranes, neonatal asphyxia, meconium staining of the amniotic fluid and maternal anemia were significantly higher than those in the cord blood sampled from normal neonates. The stress given to neonates may account for the higher M-CSF levels rather than infections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922567     DOI: 10.1016/0378-3782(96)01766-5

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  5 in total

1.  Reaction patterns of pulmonary macrophages in protracted asphyxiation.

Authors:  Theresa Strunk; Dorothee Hamacher; Ronald Schulz; Bernd Brinkmann
Journal:  Int J Legal Med       Date:  2010-02-12       Impact factor: 2.686

2.  Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity.

Authors:  Yangtai Guan; Shuo Yu; Zhao Zhao; Bogoljub Ciric; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2007-11-19       Impact factor: 3.478

3.  TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors.

Authors:  Geling Li; Saeid Abediankenari; Young-June Kim; Timothy B Campbell; Shigeki Ito; Barbara Graham-Evans; Scott Cooper; Hal E Broxmeyer
Journal:  Blood       Date:  2007-06-21       Impact factor: 22.113

Review 4.  Calprotectin in Lung Diseases.

Authors:  Ourania S Kotsiou; Dimitrios Papagiannis; Rodanthi Papadopoulou; Konstantinos I Gourgoulianis
Journal:  Int J Mol Sci       Date:  2021-02-08       Impact factor: 5.923

5.  Impaired functional capacity of polarised neonatal macrophages.

Authors:  Stephan Dreschers; Kim Ohl; Nora Schulte; Klaus Tenbrock; Thorsten W Orlikowsky
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.